Introduksjon
Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for David L Kemmerly. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.
Gjennomsnittlig handelslønnsomhet
Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,
Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.
Oppdateringsfrekvens: Daglig
Selskaper med rapporterte insiderposisjoner
SEC-arkiveringene indikerer at David L Kemmerly har rapporterte beholdninger av handler i følgende selskaper:
Verdipapir | Navn | Siste rapporterte høydepunkter |
---|---|---|
US:AMED / Amedisys, Inc. | See Remarks | 16 336 |
Hvordan tolke diagrammene
De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av David L Kemmerly. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.
Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.
Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.
Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.
Innsidernes handelshistorikk
Tabellen viser den komplette listen over innsidehandler gjort av David L Kemmerly som avslørt til Securies Exchange Comission (SEC).
Fildato | Transaksjonsdato | Skjema | Ticker | Verdipapir | Kode | Aksjer | Gjenværende aksjer | Prosent endring |
Aksje pris |
Transaksjons verdi |
Gjenværende verdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-04-04 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | X | −443 | 16 336 | −2,64 | 177,89 | −78 805 | 2 906 011 |
2022-04-04 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | X | −2 037 | 16 779 | −10,83 | 177,21 | −360 977 | 2 973 407 |
2022-04-04 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | X | −20 | 18 816 | −0,11 | 175,16 | −3 503 | 3 295 811 |
2022-02-22 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −1 161 | 18 836 | −5,81 | 141,07 | −163 782 | 2 657 195 | |
2022-02-22 |
|
4 | AMED |
AMEDISYS INC
Restricted Share Units (Performance-Based Vesting) |
A - Award | 2 618 | 2 618 | |||||
2022-02-22 |
|
4 | AMED |
AMEDISYS INC
Stock Option (Right to Buy) |
A - Award | 3 060 | 3 060 | |||||
2022-02-22 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
A - Award | 1 309 | 19 997 | 7,00 | ||||
2021-04-29 |
|
4 | AMED |
AMEDISYS INC
Stock Option (Right to Buy) |
M - Exercise | −3 125 | 0 | −100,00 | ||||
2021-04-29 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | X | −4 875 | 18 667 | −20,71 | 290,12 | −1 414 335 | 5 415 670 |
2021-04-29 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 3 125 | 23 542 | 15,31 | 27,35 | 85 469 | 643 874 | |
2021-04-13 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | X | −500 | 20 413 | −2,39 | 280,00 | −140 000 | 5 715 640 |
2021-04-02 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | X | −503 | 20 913 | −2,35 | 270,00 | −135 810 | 5 646 510 |
2021-02-23 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −521 | 21 416 | −2,37 | 292,48 | −152 382 | 6 263 752 | |
2021-02-23 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −84 | 21 937 | −0,38 | 292,48 | −24 568 | 6 416 134 | |
2021-02-23 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −131 | 22 021 | −0,59 | 292,48 | −38 315 | 6 440 702 | |
2021-02-19 |
|
4 | AMED |
AMEDISYS INC
Restricted Stock Unit (Performance-Based Vesting) |
A - Award | 1 271 | 1 271 | |||||
2021-02-19 |
|
4 | AMED |
AMEDISYS INC
Stock Option (Right to Buy) |
A - Award | 1 600 | 1 600 | |||||
2021-02-19 |
|
4 | AMED |
AMEDISYS INC
Restricted Share Units (Performance-Based Vesting) |
M - Exercise | −1 698 | 0 | −100,00 | ||||
2021-02-19 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
A - Award | 3 388 | 22 152 | 18,06 | ||||
2021-02-19 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
A - Award | 636 | 18 764 | 3,51 | ||||
2021-02-19 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −347 | 18 128 | −1,88 | 295,20 | −102 434 | 5 351 386 | |
2021-02-19 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 3 396 | 18 475 | 22,52 | ||||
2020-06-11 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | X | −315 | 15 063 | −2,05 | 176,10 | −55 472 | 2 652 594 |
2020-06-11 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | X | −631 | 15 378 | −3,94 | 176,80 | −111 561 | 2 718 830 |
2020-06-11 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | X | −1 263 | 16 009 | −7,31 | 177,00 | −223 551 | 2 833 593 |
2020-06-08 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −820 | 17 272 | −4,53 | 176,03 | −144 345 | 3 040 390 | |
2020-06-08 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −410 | 18 092 | −2,22 | 176,03 | −72 172 | 3 184 735 | |
2020-06-08 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −1 640 | 18 502 | −8,14 | 176,03 | −288 689 | 3 256 907 | |
2020-05-07 |
|
4 | AMED |
AMEDISYS INC
Stock Option (right to buy) |
M - Exercise | −3 125 | 3 125 | −50,00 | ||||
2020-05-07 |
|
4 | AMED |
AMEDISYS INC
Stock Option (right to buy) |
M - Exercise | −1 562 | 1 563 | −49,98 | ||||
2020-05-07 |
|
4 | AMED |
AMEDISYS INC
Stock Option (right to buy) |
M - Exercise | −18 750 | 0 | −100,00 | ||||
2020-05-07 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | X | −393 | 20 142 | −1,91 | 176,80 | −69 482 | 3 561 106 |
2020-05-07 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | X | −6 044 | 20 535 | −22,74 | 176,04 | −1 063 986 | 3 614 981 |
2020-05-07 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | X | −13 858 | 26 579 | −34,27 | 175,17 | −2 427 506 | 4 655 843 |
2020-05-07 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | X | −3 142 | 40 437 | −7,21 | 174,41 | −547 996 | 7 052 617 |
2020-05-07 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 3 125 | 43 579 | 7,72 | 27,35 | 85 469 | 1 191 886 | |
2020-05-07 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 1 562 | 40 454 | 4,02 | 27,35 | 42 721 | 1 106 417 | |
2020-05-07 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 18 750 | 38 892 | 93,09 | 27,35 | 512 812 | 1 063 696 | |
2020-02-26 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | X | −202 | 20 137 | −0,99 | 191,88 | −38 760 | 3 863 888 |
2020-02-26 |
|
4 | AMED |
AMEDISYS INC
Stock Option (right to buy) |
M - Exercise | −725 | 2 173 | −25,02 | ||||
2020-02-26 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | X | −391 | 20 339 | −1,89 | 186,87 | −73 066 | 3 800 749 |
2020-02-26 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | X | −725 | 20 730 | −3,38 | 186,87 | −135 481 | 3 873 815 |
2020-02-26 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 725 | 21 455 | 3,50 | 127,11 | 92 155 | 2 727 145 | |
2020-02-24 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −130 | 20 730 | −0,62 | 194,12 | −25 236 | 4 024 108 | |
2020-02-14 |
|
4 | AMED |
AMEDISYS INC
Restricted Stock Unit (Performance-Based Vesting) |
A - Award | 1 698 | 1 698 | |||||
2020-02-14 |
|
4 | AMED |
AMEDISYS INC
Stock Option (Right to Buy) |
A - Award | 2 023 | 2 023 | |||||
2020-02-14 |
|
4 | AMED |
AMEDISYS INC
Restricted Stock Unit (Performance-Based Vesting) |
M - Exercise | −2 656 | 0 | −100,00 | ||||
2020-02-14 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
A - Award | 849 | 20 860 | 4,24 | ||||
2020-02-14 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −540 | 20 011 | −2,63 | 198,81 | −107 357 | 3 978 387 | |
2020-02-14 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 5 292 | 20 551 | 34,68 | ||||
2019-06-12 |
|
4 | AMED |
AMEDISYS INC
Stock Option (right to buy) |
M - Exercise | −3 125 | 6 250 | −33,33 | ||||
2019-06-12 |
|
4 | AMED |
AMEDISYS INC
Stock Option (right to buy) |
M - Exercise | −3 125 | 6 250 | −33,33 | ||||
2019-06-12 |
|
4 | AMED |
AMEDISYS INC
Stock Option (right to buy) |
M - Exercise | −1 875 | 0 | −100,00 | ||||
2019-06-12 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | −8 125 | 15 232 | −34,79 | 117,77 | −956 881 | 1 793 873 | |
2019-06-12 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 3 125 | 23 357 | 15,45 | 27,35 | 85 469 | 638 814 | |
2019-06-12 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 3 125 | 23 357 | 15,45 | 27,35 | 85 469 | 638 814 | |
2019-06-12 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 1 875 | 17 107 | 12,31 | 27,35 | 51 281 | 467 876 | |
2019-06-06 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | −4 420 | 15 232 | −22,49 | 113,40 | −501 228 | 1 727 309 | |
2019-06-06 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −411 | 19 652 | −2,05 | 113,49 | −46 644 | 2 230 305 | |
2019-06-06 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −411 | 19 652 | −2,05 | 113,49 | −46 644 | 2 230 305 | |
2019-06-06 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −410 | 20 474 | −1,96 | 113,49 | −46 531 | 2 323 594 | |
2019-06-06 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −1 640 | 20 884 | −7,28 | 113,49 | −186 124 | 2 370 125 | |
2019-06-03 |
|
4 | AMED |
AMEDISYS INC
Stock Option (right to buy) |
M - Exercise | −1 250 | 1 875 | −40,00 | ||||
2019-06-03 |
|
4 | AMED |
AMEDISYS INC
Stock Option (right to buy) |
M - Exercise | −3 750 | 18 750 | −16,67 | ||||
2019-06-03 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | −5 000 | 22 524 | −18,17 | 113,48 | −567 400 | 2 556 024 | |
2019-06-03 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 1 250 | 27 524 | 4,76 | 27,35 | 34 188 | 752 781 | |
2019-06-03 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 3 750 | 26 274 | 16,65 | 27,35 | 102 562 | 718 594 | |
2019-05-21 |
|
4 | AMED |
AMEDISYS INC
Stock Option (right to buy) |
M - Exercise | −5 000 | 22 500 | −18,18 | ||||
2019-05-21 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | −5 000 | 22 524 | −18,17 | 109,96 | −549 800 | 2 476 739 | |
2019-05-21 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 5 000 | 27 524 | 22,20 | 27,35 | 136 750 | 752 781 | |
2019-05-14 |
|
4 | AMED |
AMEDISYS INC
Stock Option (right to buy) |
M - Exercise | −5 000 | 27 500 | −15,38 | ||||
2019-05-14 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | −1 874 | 22 524 | −7,68 | 116,95 | −219 164 | 2 634 182 | |
2019-05-14 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | −242 | 24 398 | −0,98 | 114,76 | −27 772 | 2 799 914 | |
2019-05-14 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | −2 884 | 24 640 | −10,48 | 114,04 | −328 891 | 2 809 946 | |
2019-05-14 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 5 000 | 27 524 | 22,20 | 27,35 | 136 750 | 752 781 | |
2019-05-09 |
|
4 | AMED |
AMEDISYS INC
Stock Option (right to buy) |
M - Exercise | −5 000 | 32 500 | −13,33 | ||||
2019-05-09 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | −100 | 22 524 | −0,44 | 119,32 | −11 932 | 2 687 564 | |
2019-05-09 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | −4 900 | 22 624 | −17,80 | 118,18 | −579 082 | 2 673 704 | |
2019-05-09 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 5 000 | 27 524 | 22,20 | 27,35 | 136 750 | 752 781 | |
2019-02-22 |
|
4 | AMED |
AMEDISYS INC
Restricted Stock Units |
A - Award | 2 656 | 2 656 | |||||
2019-02-22 |
|
4 | AMED |
AMEDISYS INC
Stock Option (Right to Buy) |
A - Award | 2 898 | 2 898 | |||||
2019-02-22 |
|
4 | AMED |
AMEDISYS INC
Stock Option (Right to Buy) |
A - Award | 9 375 | 9 375 | |||||
2019-02-22 |
|
4 | AMED |
AMEDISYS INC
Restricted Stock Units |
M - Exercise | −3 125 | 0 | −100,00 | ||||
2019-02-22 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
A - Award | 1 328 | 22 515 | 6,27 | ||||
2019-02-22 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 3 125 | 21 187 | 17,30 | ||||
2018-12-14 |
|
4 | AMED |
AMEDISYS INC
Stock Option (right to buy) |
M - Exercise | −3 125 | 6 250 | −33,33 | ||||
2018-12-14 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | −3 125 | 18 052 | −14,76 | 133,82 | −418 188 | 2 415 719 | |
2018-12-14 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 3 125 | 21 177 | 17,31 | 27,35 | 85 469 | 579 191 | |
2018-11-16 |
|
4 | AMED |
AMEDISYS INC
Stock Option (right to buy) |
M - Exercise | −3 125 | 3 125 | −50,00 | ||||
2018-11-16 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | −2 034 | 18 052 | −10,13 | 117,02 | −238 019 | 2 112 445 | |
2018-11-16 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | −1 091 | 20 086 | −5,15 | 116,61 | −127 222 | 2 342 228 | |
2018-11-16 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 3 125 | 21 177 | 17,31 | 27,35 | 85 469 | 579 191 | |
2018-11-09 |
|
4 | AMED |
AMEDISYS INC
Stock Option (right to buy) |
M - Exercise | −3 125 | 6 250 | −33,33 | ||||
2018-11-09 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | −405 | 18 052 | −2,19 | 121,11 | −49 050 | 2 186 278 | |
2018-11-09 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | −2 720 | 18 457 | −12,84 | 120,31 | −327 243 | 2 220 562 | |
2018-11-09 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 3 125 | 21 177 | 17,31 | 27,35 | 85 469 | 579 191 | |
2018-11-09 |
|
4 | AMED |
AMEDISYS INC
Stock Option (right to buy) |
M - Exercise | −3 375 | 0 | −100,00 | ||||
2018-11-09 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | −3 375 | 18 052 | −15,75 | 117,44 | −396 360 | 2 120 027 | |
2018-11-09 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 3 375 | 21 427 | 18,70 | 27,35 | 92 306 | 586 028 | |
2018-06-11 |
|
4 | AMED |
AMEDISYS INC
Stock Option (right to buy) |
M - Exercise | −6 000 | 3 375 | −64,00 | ||||
2018-06-11 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | −1 700 | 18 028 | −8,62 | 79,86 | −135 762 | 1 439 716 | |
2018-06-11 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
S - Sale | −4 300 | 19 728 | −17,90 | 78,69 | −338 367 | 1 552 396 | |
2018-06-11 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 6 000 | 24 028 | 33,28 | 27,35 | 164 100 | 657 166 | |
2018-06-06 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −410 | 18 028 | −2,22 | 77,04 | −31 586 | 1 388 877 | |
2018-06-06 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −410 | 18 028 | −2,22 | 77,04 | −31 586 | 1 388 877 | |
2018-06-06 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −410 | 19 075 | −2,10 | 77,04 | −31 586 | 1 469 538 | |
2018-06-06 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −1 638 | 19 258 | −7,84 | 77,04 | −126 192 | 1 483 636 | |
2018-02-22 |
|
4 | AMED |
AMEDISYS INC
Stock Option (Right to Buy) |
A - Award | 9 375 | 9 375 | |||||
2018-02-22 |
|
4 | AMED |
AMEDISYS INC
Restricted Stock Units |
M - Exercise | −3 125 | 3 125 | −50,00 | ||||
2018-02-22 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 3 125 | 20 879 | 17,60 | ||||
2017-06-06 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −435 | 17 707 | −2,40 | 60,27 | −26 217 | 1 067 201 | |
2017-06-06 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −435 | 18 147 | −2,34 | 60,27 | −26 217 | 1 093 720 | |
2017-02-24 |
|
4 | AMED |
AMEDISYS INC
Stock Option (Right to Buy) |
A - Award | 9 375 | 9 375 | |||||
2017-02-24 |
|
4 | AMED |
AMEDISYS INC
Restricted Stock Units |
M - Exercise | −3 125 | 6 250 | −33,33 | ||||
2017-02-24 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 3 125 | 18 577 | 20,22 | ||||
2016-06-07 |
|
4 | AMED |
AMEDISYS INC
Restricted Stock Units |
M - Exercise | −3 125 | 9 375 | −25,00 | ||||
2016-06-07 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
F - Taxes | −285 | 15 452 | −1,81 | 52,56 | −14 980 | 812 157 | |
2016-06-07 |
|
4 | AMED |
AMEDISYS INC
Common Stock |
M - Exercise | 3 125 | 15 737 | 24,78 | ||||
2016-05-02 | 3 | AMED |
AMEDISYS INC
Common Stock |
25 224 | ||||||||
2016-05-02 | 3 | AMED |
AMEDISYS INC
Common Stock |
25 224 |